News Releases

UC DAVIS INITIATES STUDY OF EFFECTS OF CABERNAYZYN™ ON GROUP WITH INCREASED RISK FOR CARDIOVASCULAR DISEASE
For further information: Eleanor Cates - eleanor@rayzyn.com - 404.375.3700